nGL 12.5 (Movantik 12.5 mg)
Generic Name: naloxegol
Pill with imprint nGL 12.5 is Purple, Elliptical / Oval and has been identified as Movantik 12.5 mg. It is supplied by AstraZeneca Pharmaceuticals LP.
Movantik is used in the treatment of opioid-induced constipation; constipation, chronic; constipation, drug induced and belongs to the drug class peripheral opioid receptor antagonists. Risk cannot be ruled out during pregnancy. Movantik 12.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for nGL 12.5
Movantik
- Generic Name:
- naloxegol
- Imprint:
- nGL 12.5
- Strength:
- 12.5 mg
- Color:
- Purple
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Peripheral opioid receptor antagonists
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- AstraZeneca Pharmaceuticals LP
- National Drug Code (NDC):
- 00310-1969
More about Movantik (naloxegol)
- Movantik Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 176 Reviews
- Drug class: peripheral opioid receptor antagonists
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
